Table 2 Characteristics of included SRs/MAs
Study ID | Country | Language | Study type | trials (cases) | Intervention(T/C) | Quality assessmnet | Main results | Funding | Interest statement | |
|---|---|---|---|---|---|---|---|---|---|---|
Yang AL 2018 [29] | China | Chinese | RCT | 7(542) | SFI+CT | CT | Cochrane risk of bias tool | ①③ | N | N |
Wu JH 2019 [8] | China | English | RCT | 20 (2095) | SFI+CT | CT | Cochrane risk of bias tool | ①②③④ | N | N |
Liu SY 2018 [6] | China | English | RCT | 31 (2543) | SFI+CT | CT | Cochrane risk of bias tool | ①②③④ | Y | Y |
Lv YH 2015 [30] | China | English | RCT | 18 (1247) | SFI+CT | CT | Cochrane risk of bias tool and JADAD | ①②③④ | Y | Y |
Li Y 2016 [31] | China | English | RCT | 20 (1609) | SFI+CT | CT | Cochrane risk of bias tool | ①②③④ | N | Y |
Zhang HB 2019 [7] | China | English | RCT | 49 (4385) | SFI+CT | CT | Cochrane risk of bias tool | ①②③④ | N | Y |